EA202193155A1 - Селективные антагонисты h3-гистаминовых рецепторов для лечения расстройства аутистического спектра - Google Patents
Селективные антагонисты h3-гистаминовых рецепторов для лечения расстройства аутистического спектраInfo
- Publication number
- EA202193155A1 EA202193155A1 EA202193155A EA202193155A EA202193155A1 EA 202193155 A1 EA202193155 A1 EA 202193155A1 EA 202193155 A EA202193155 A EA 202193155A EA 202193155 A EA202193155 A EA 202193155A EA 202193155 A1 EA202193155 A1 EA 202193155A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- treatment
- receptor antagonists
- selective
- autism spectrum
- histamine receptor
- Prior art date
Links
- 208000029560 autism spectrum disease Diseases 0.000 title abstract 3
- 229940122236 Histamine receptor antagonist Drugs 0.000 title 1
- BDDVHFUUXVOMBE-QGZVFWFLSA-N 1-[4-[4-[3-[(2r)-2-methylpyrrolidin-1-yl]propoxy]phenoxy]piperidin-1-yl]ethanone Chemical compound C[C@@H]1CCCN1CCCOC(C=C1)=CC=C1OC1CCN(C(C)=O)CC1 BDDVHFUUXVOMBE-QGZVFWFLSA-N 0.000 abstract 1
- 229940115480 Histamine H3 receptor antagonist Drugs 0.000 abstract 1
- 229940122931 Histamine H3 receptor inverse agonist Drugs 0.000 abstract 1
- 239000003395 histamine H3 receptor antagonist Substances 0.000 abstract 1
- 239000002207 metabolite Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
- A61J3/07—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of capsules or similar small containers for oral use
- A61J3/071—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of capsules or similar small containers for oral use into the form of telescopically engaged two-piece capsules
- A61J3/074—Filling capsules; Related operations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HUP1900190A HU231525B1 (hu) | 2019-05-31 | 2019-05-31 | Szelektív hisztamin H3 receptor antagonisták autizmus spektrum betegség kezelésére |
| PCT/IB2020/055104 WO2020240489A1 (en) | 2019-05-31 | 2020-05-29 | Selective histamine h3 receptor antagonists for treating autism spectrum disorder |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EA202193155A1 true EA202193155A1 (ru) | 2022-03-22 |
Family
ID=89992916
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EA202193155A EA202193155A1 (ru) | 2019-05-31 | 2020-05-29 | Селективные антагонисты h3-гистаминовых рецепторов для лечения расстройства аутистического спектра |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20220235034A1 (https=) |
| EP (1) | EP3976035A1 (https=) |
| JP (1) | JP2022534973A (https=) |
| CN (1) | CN113905736A (https=) |
| CA (1) | CA3141694A1 (https=) |
| EA (1) | EA202193155A1 (https=) |
| HU (1) | HU231525B1 (https=) |
| WO (1) | WO2020240489A1 (https=) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE354568T1 (de) * | 2000-08-08 | 2007-03-15 | Ortho Mcneil Pharm Inc | Nicht-imidazol aryloxypiperidine als h3 rezeptor liganden |
| HUP1300139A2 (en) * | 2013-03-06 | 2014-09-29 | Richter Gedeon Nyrt | Phenoxypiperidine h3 antagonists |
-
2019
- 2019-05-31 HU HUP1900190A patent/HU231525B1/hu unknown
-
2020
- 2020-05-29 WO PCT/IB2020/055104 patent/WO2020240489A1/en not_active Ceased
- 2020-05-29 CN CN202080040238.0A patent/CN113905736A/zh active Pending
- 2020-05-29 CA CA3141694A patent/CA3141694A1/en active Pending
- 2020-05-29 EP EP20730490.8A patent/EP3976035A1/en not_active Withdrawn
- 2020-05-29 EA EA202193155A patent/EA202193155A1/ru unknown
- 2020-05-29 JP JP2021570821A patent/JP2022534973A/ja active Pending
- 2020-05-29 US US17/614,412 patent/US20220235034A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| HU231525B1 (hu) | 2024-08-28 |
| US20220235034A1 (en) | 2022-07-28 |
| CA3141694A1 (en) | 2020-12-03 |
| JP2022534973A (ja) | 2022-08-04 |
| WO2020240489A1 (en) | 2020-12-03 |
| CN113905736A (zh) | 2022-01-07 |
| EP3976035A1 (en) | 2022-04-06 |
| HUP1900190A1 (hu) | 2020-12-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2017003215A (es) | Terapia de combinacion con cenicriviroc para el tratamiento de la fibrosis. | |
| HK1258396A1 (zh) | 用於治疗纤维化的赛尼克韦罗联合疗法 | |
| Karpel-Massler et al. | Olanzapine inhibits proliferation, migration and anchorage-independent growth in human glioblastoma cell lines and enhances temozolomide’s antiproliferative effect | |
| CL2012002739A1 (es) | Compuesto (r)-n-(3-(7-metil-1h-indazol-5-il)-1-(4-(1-metilpiperidin-4-il)piperazin-1-il)-1-oxopropan-2-il)-4-(2-oxo-1,2-dihidroquinolin-3-il)piperidina-1-carboxamida; composicion farmaceutica que lo comprende; uso del compuesto para el tratamiento de migraña, dolor neuropático, cancer de mama y glioma. | |
| MX2020007898A (es) | Moduladores de cinasa de proteina asociada con rho. | |
| MX369576B (es) | Imidazoles 2-piridilo sustituidos como inhibidores de alk5 y/o alk4. | |
| MX2019003726A (es) | Metodos para tratar fibroides uterinos y endometriosis. | |
| UA112514C2 (uk) | АНТАГОНІСТИ C5aR | |
| MX386113B (es) | Polimorfos de n-[(3-fluoro-4-metoxipiridin-2-il)metil]-3-(metoximetil)-1-({4-[(2-oxopiridin-1-il)metil]fenil}metil)pirazol-4-carboxamida y sales de los mismos. | |
| PE20120626A1 (es) | Composiciones farmaceuticas que comprende nilotinib | |
| MX2015018032A (es) | Análogos sustituidos de (e)-n'-(1-feniletiliden)benzohidrazida como inhibidores de histona desmetilasa. | |
| MX2016004342A (es) | Formulaciones de (s)-3-(4-((4-morfolinometil)bencil)oxi)-1-oxoisoi ndolin-2-il)piperidin-2,6-diona. | |
| MX2017010348A (es) | Compuestos de amida como agonistas del receptor de la 5-hidroxitriptamina 4 (5-ht4). | |
| EA202192320A1 (ru) | Кристаллическая форма моногидрата 1-(1-оксо-1,2-дигидроизохинолин-5-ил)-5-(трифторметил)-n-[2-(трифторметил)пиридин-4-ил]-1h-пиразол-4-карбоксамида | |
| SA522441554B1 (ar) | Ripk1 مركبات أيزوكسازوليدين كمثبطات واستخدامها | |
| MX2020008375A (es) | Compuestos de heteroarilo, composiciones farmaceuticas de los mismos y su uso terapeutico. | |
| EA201890764A1 (ru) | Селективные антагонисты nr2b | |
| EA201692474A1 (ru) | Производные 1-(циклопент-2-ен-1-ил)-3-(2-гидрокси-3-(арилсульфонил)фенил)мочевины в качестве ингибиторов cxcr2 | |
| CY1124056T1 (el) | Κρυσταλλικες μορφες της μηλεϊνικης 1-((2r, 4r)-2-(1η-βενζο[d] iμιδαζολ-2-υλο)-1-μεθυλοπιπεριδιν-4-υλο)-3-(4-κυανοφαινυλ) ουριας | |
| MX388589B (es) | Nuevo uso terapeutico de h3-ligandos. | |
| EA201992704A1 (ru) | Новое применение агониста формил-пептидного рецептора 2/рецептора липоксина a4 (fpr2/alx) для лечения сердечной недостаточности | |
| EA201691160A1 (ru) | Антагонисты s1p3 | |
| EA202193155A1 (ru) | Селективные антагонисты h3-гистаминовых рецепторов для лечения расстройства аутистического спектра | |
| MX379454B (es) | Derivados de fluoroindol como moduladores alostéricos positivos del receptor m1 muscarínico. | |
| EA201892528A1 (ru) | Трехкомпонентная комбинация чистых антагонистов 5-htрецепторов, ингибиторов ацетилхолинэстеразы и антагониста nmda рецептора |